Drug Abuse Science Gets Partial Public Peep Show
Published Date: 3/25/2025
Notice
Summary
The National Institute on Drug Abuse is holding a virtual meeting on May 13, 2025, to review grant applications and discuss important drug research topics. This meeting affects researchers and organizations seeking funding, with some parts open to the public and others private to protect sensitive info. No direct money changes are announced, but grant decisions could impact future funding.
Analyzed Economic Effects
5 provisions identified: 4 benefits, 0 costs, 1 mixed.
NIDA Will Review Grant Applications
On May 13, 2025, the National Advisory Council on Drug Abuse will meet virtually to review and evaluate grant applications (closed session 11:00 a.m. to 12:15 p.m.). This meeting directly concerns researchers and organizations that have submitted grant applications to the Institute.
Open Session Videocast for Public Viewing
The Council's open session on May 13, 2025, from 1:30 p.m. to 5:00 p.m. will be videocast and can be accessed from the NIH Videocasting and Podcasting website. Anyone may view the presentations and business of the Council via that videocast.
Portion Closed to Protect Confidential Information
A portion of the May 13, 2025 meeting (11:00 a.m. to 12:15 p.m.) will be closed to the public under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, commercial property, patentable material, and personal information tied to grant applications. That closed review applies to applicants whose materials could disclose confidential or personally sensitive information.
Anyone May File Written Comments
Any interested person may file written comments for the committee by emailing Dr. Gillian Acca; comments should include name, address, telephone number, and, when applicable, business or professional affiliation. The notice provides a clear, open channel for public input to the Council.
Accessibility Accommodations Available by Request
Individuals who plan to view the virtual meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Dr. Gillian Acca by email five days before the May 13, 2025 meeting. The Institute provides a process to request accommodations for the videocast.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10021 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to health and cancer research. These meetings are private to protect sensitive information and personal privacy. Researchers applying for grants and NIH staff are the main players, with no direct cost changes announced but important deadlines to keep in mind.
2026-09947 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting health science projects. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10022 — Submission for OMB Review; 30-Day Comment Request; Early Career Reviewer Program Online Application and Vetting System (Center for Scientific Review)
The NIH wants your thoughts on their Early Career Reviewer Program’s new online application and review system. This affects early career scientists applying to review research, making the process smoother and digital. You’ve got 30 days to share your feedback—no cost changes, just a smarter way to apply!
2026-09852 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on important research grant applications. These meetings keep sensitive info private, protecting personal and trade secrets. Scientists applying for grants and the research community should note these dates as they impact funding decisions.
2026-09324 — National Institute of Allergy and Infectious Diseases; Notice of Meetings
The National Institute of Allergy and Infectious Diseases is holding virtual meetings on June 22, 2026, to review grant applications and share important updates. These meetings affect researchers and organizations seeking funding, with some sessions open to the public online and others closed to protect privacy. No new funding amounts are announced, but the grant review could impact future research support.
2026-09323 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late May and June 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research institutions waiting on grants should note these dates as they impact funding decisions.
Previous / Next Documents
Previous: 2025-04980 — National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a private virtual meeting on May 1, 2025, to review grant applications. This meeting affects researchers seeking funding for diabetes, digestive, and kidney disease studies. No public access or money changes are involved, but the review helps decide who gets research support.
Next: 2025-04982 — Certain Active Matrix Organic Light-Emitting Diode Display Panels and Modules for Mobile Devices, and Components Thereof; Notice of the Commission's Final Determination Finding No Violation of Section 337; Termination of the Investigation
The U.S. International Trade Commission looked into certain OLED display panels and parts used in mobile devices and found no rule-breaking. This means the investigation is over, and companies can keep making and selling these products without worry. No fines or penalties are coming, so business stays smooth and steady.